Broad John, Sanger Gareth J
Neurogastroenterology Group, Blizard Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, UK.
Br J Pharmacol. 2013 Apr;168(8):1859-67. doi: 10.1111/bph.12077.
The antibiotic azithromycin is a suggested alternative to erythromycin for treating patients with delayed gastric emptying. However, although hypothesized to activate motilin receptors, supportive evidence is unavailable. This was investigated using recombinant and naturally expressed motilin receptors in human stomach, comparing azithromycin with erythromycin.
[(125)I]-motilin binding and calcium flux experiments were conducted using human recombinant motilin receptors in CHO cells. Neuromuscular activities were studied using circular muscle of human gastric antrum, after electrical field stimulation (EFS) of intrinsic nerves.
Azithromycin (1-100 μM) and erythromycin (3-30 μM) concentration-dependently displaced [(125)I]-motilin binding to the motilin receptor (52 ± 7 and 58 ± 18% displacement at 100 and 30 μM respectively). Azithromycin, erythromycin and motilin concentration-dependently caused short-lived increases in intracellular [Ca(2+)] in cells expressing the motilin receptor. EC50 values were, respectively, 2.9, 0.92 and 0.036 μM (n = 3 each); and maximal activities were similar. In human stomach, EFS evoked cholinergically mediated contractions, attenuated by simultaneous nitrergic activation. Azithromycin and erythromycin lactobionate (30-300 μM each) facilitated these contractions (apparent E(max) values of 2007 ± 396 and 1924 ± 1375%, n = 3-4 each concentration, respectively). These actions were slow in onset and faded slowly. The higher concentrations also evoked short-lived muscle contraction. Contractions to a submaximally effective concentration of carbachol were unaffected by either drug.
Azithromcyin activates human recombinant motilin receptors in therapeutically relevant concentrations, similar to erythromycin. In humans, gastric antrum azithromycin caused long-lasting facilitation of cholinergic activity. These actions explain the gastric prokinetic activity of azithromycin.
抗生素阿奇霉素被认为是治疗胃排空延迟患者的红霉素替代药物。然而,尽管推测其可激活胃动素受体,但缺乏支持性证据。本研究利用人胃中重组和天然表达的胃动素受体,将阿奇霉素与红霉素进行比较,以对此进行探究。
使用CHO细胞中的人重组胃动素受体进行[¹²⁵I] - 胃动素结合和钙流实验。在内源性神经进行电场刺激(EFS)后,利用人胃窦环形肌研究神经肌肉活动。
阿奇霉素(1 - 100 μM)和红霉素(3 - 30 μM)浓度依赖性地使[¹²⁵I] - 胃动素与胃动素受体的结合发生位移(在100 μM和30 μM时分别有52 ± 7%和58 ± 18%的位移)。阿奇霉素、红霉素和胃动素浓度依赖性地使表达胃动素受体的细胞内[Ca²⁺]短暂升高。EC50值分别为2.9 μM、0.92 μM和0.036 μM(每组n = 3);最大活性相似。在人胃中,EFS诱发胆碱能介导的收缩,并被同时的一氧化氮能激活所减弱。阿奇霉素和乳糖酸红霉素(各30 - 300 μM)促进了这些收缩(各浓度下的表观E(max)值分别为2007 ± 396%和1924 ± 1375%,每组n = 3 - 4)。这些作用起效缓慢且消退缓慢。较高浓度还诱发短暂的肌肉收缩。两种药物对低于最大有效浓度的卡巴胆碱引起的收缩均无影响。
阿奇霉素在治疗相关浓度下可激活人重组胃动素受体,与红霉素相似。在人体中,胃窦阿奇霉素可导致胆碱能活性的长期增强。这些作用解释了阿奇霉素的胃促动力活性。